Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT07321925 Sponsor: Endra Lifesciences Condition: Non-Alcoholic Fatty Liver Disease
Back to Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Trial, Recruiting

NCT07321925
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older.
  • People who are able to read, understand, and sign a consent form written in English.
  • People who are able to tolerate both ultrasound and MRI scans.
  • People who are able to lie flat or on their side for 20 minutes and hold their breath for up to 10 seconds at a time.

Who may not be able to join:

  • People who have metal or electronic devices inside their body — such as pacemakers, metal clips, drug delivery pumps, hip implants, or nerve stimulation devices — that are not safe for MRI scans.
  • People who are pregnant on the day of consent, or who become pregnant during the study period.
  • People who have liver conditions other than MASLD, MASH, or liver fibrosis — for example, cirrhosis, liver cancer (hepatocellular carcinoma), or fluid build-up in the abdomen (ascites).
  • People who have broken or damaged skin on the upper right area of the abdomen.
  • People whose liver cannot be clearly viewed using a standard ultrasound scan through the right side of the ribcage (confirm with trial site).
  • People with a BMI greater than 50 kg/m².
  • People whose layer of fat just beneath the skin at the measurement location measures 6mm or less.
  • People who are missing a lobe of the liver.
  • People who have fat surrounding the liver at the measurement location.
  • People who have focal liver lesions (abnormal spots or growths) or other anatomical structures detected by ultrasound at the measurement location.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 415-531-4647

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Endra Lifesciences
Registry
ClinicalTrials.gov
Start date
15 August 2025
Est. completion
30 October 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Correlation between Thermoacoustic Fat Fraction (TAFF) and the MRI-PDFF

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov